Body Fluid Balance Calculator by Inputs and Outputs
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۲۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Significant Negative Balance-1000–-500
- Moderate Negative Balance-500–-200
- Neutral Balance-200–200
- Moderate Positive Balance200–500
The Body Fluid Balance Calculator by Inputs and Outputs calculates calculating fluid balance from sodium concentrations indicating 0. Key inputs include gastric losses. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Calculates fluid balance from sodium concentrations indicating 0.9% saline fluid, and free water losses (GI, urine, etc) and gains (IV fluids, PO, etc). Helps track complex fluid dynamics in hospitalized patients by accounting for different sodium concentrations in various fluids.
Clinical Indication
The Body Fluid Balance Calculator by Inputs and Outputs is indicated for bedside clinical practice to support Calculates fluid balance from sodium concentrations indicating 0.9% saline fluid, and free water losses (GI, urine, etc) and gains (IV fluids, PO, etc). Helps track complex fluid dynamics in hospitalized patients by accounting for different sodium concentrations in various fluids.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.
Limitations & Contraindications
eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass.
Clinical Pearls & Action Plan
Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI.
Net Fluid Balance = Total Fluid Gains - Total Fluid Losses. 0.9% Saline Balance = (Volume × Na concentration / 154) for each fluid. Free Water Balance = Volume × (1 - Na concentration / 154) for each fluid.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| gastric_losses | float | No | Volume of gastric losses in mL (sodium concentration ~60 mEq/L)(mL) |
| biliary_losses | float | No | Volume of biliary losses in mL (sodium concentration ~130 mEq/L)(mL) |
| small_bowel_losses | float | No | Volume of small bowel losses in mL (sodium concentration ~110 mEq/L)(mL) |
| diarrhea_losses | float | No | Volume of diarrhea losses in mL (sodium concentration ~60 mEq/L)(mL) |
| urine_output | float | No | Volume of urine output in mL (sodium concentration variable, typically 40 mEq/L)(mL) |
| insensible_losses | float | No | Estimated insensible losses in mL (pure water loss, no sodium)(mL) |
| other_losses | float | No | Other fluid losses in mL (assume isotonic, sodium ~140 mEq/L)(mL) |
| normal_saline_iv | float | No | Volume of 0.9% normal saline administered IV in mL (sodium 154 mEq/L)(mL) |
| half_normal_saline_iv | float | No | Volume of 0.45% half normal saline administered IV in mL (sodium 77 mEq/L)(mL) |
| lactated_ringers_iv | float | No | Volume of lactated Ringer's solution administered IV in mL (sodium 130 mEq/L)(mL) |
| d5w_iv | float | No | Volume of D5W (5% dextrose in water) administered IV in mL (no sodium, free water)(mL) |
| oral_intake | float | No | Volume of oral fluid intake in mL (assume free water)(mL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| -1000–-500 | Significant Negative Balance | Net fluid loss >500 mL |
| -500–-200 | Moderate Negative Balance | Net fluid loss 200-500 mL |
| -200–200 | Neutral Balance | Net fluid balance -200 to +200 mL |
| 200–500 | Moderate Positive Balance | Net fluid gain 200-500 mL |
| 500–2000 | Significant Positive Balance | Net fluid gain >500 mL |
Evidence-Based References (EBM)
- Kaptein EM, Sreeramoju D, Kaptein JS, Kaptein MJ. A systematic approach to factitious hypernatremia: A case report and review of the literature. Clin Nephrol. 2016 Apr;85(4):246-52. doi: 10.5414/CN108716.DOI: 10.5414/CN108716
- Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007 Mar 28;297(12):1319-31. doi: 10.1001/jama.297.12.1319.DOI: 10.1001/jama.297.12.1319
- Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WH. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol. 2013 Aug 6;62(6):516-24. doi: 10.1016/j.jacc.2013.05.027.DOI: 10.1016/j.jacc.2013.05.027
- Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. New York: McGraw-Hill; 2001.